Results 131 to 140 of about 27,171 (223)

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. [PDF]

Euro Surveill, 2022
Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, Levi N, Weiss L, Aguvaev I, Cohen Z, Kestin K, Vasserman R, Elul M, Fratty IS, Geva M, Wax M, Erster O, Yishai R, Hecht-Sagie L, Alroy-Preis S, Mendelson E, Weil M.   +21 more
europepmc   +1 more source

A short review on poliomyelitis: types, transmission, diagnosis, prevention, treatment

Journal of Contemporary Pharmacy
This research is focused on the impact of poliomyelitis in current era. It also explores strategies for its prevention and control. The study utilizes qualitative research methods to comprehensively explain and support interpretive goals. Secondary data
Ayna Marzia, Liaqat Ali
doaj   +2 more sources

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference. [PDF]

Clin Infect Dis, 2023
Islam MT, Date K, Khan AI, Bhuiyan TR, Khan ZH, Ahmed S, Hossain M, Khaton F, Zaman K, McMillan NAJ, Anand A, An Q, Zhang C, Weldon WC, Yu A, Luby S, Qadri F.   +16 more
europepmc   +1 more source

Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau. [PDF]

Open Forum Infect Dis, 2022
Fisker AB, Martins JSD, Nanque LM, Jensen AM, Ca EJC, Nielsen S, Martins CL, Rodrigues A.   +7 more
europepmc   +1 more source

Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections. [PDF]

Vaccines (Basel), 2021
Nielsen S, Sujan HM, Benn CS, Aaby P, Hanifi SMA.   +4 more
europepmc   +1 more source

Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV. [PDF]

Open Forum Infect Dis, 2022
Aaby P, Nielsen S, Fisker AB, Pedersen LM, Welaga P, Hanifi SMA, Martins CL, Rodrigues A, Chumakov K, Benn CS.   +9 more
europepmc   +1 more source

Effect of BCG Danish and oral polio vaccine on neonatal mortality in newborn babies weighing less than 2000 g in India: multicentre open label randomised controlled trial (BLOW2). [PDF]

BMJ
Adhisivam B, Kamalarathnam C, Bhat BV, Jayaraman K, Namachivayam SP, Shann F, McSharry B, David P, Raja, Sundaram M.   +9 more
europepmc   +1 more source

Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan. [PDF]

J Infect Dis
Sabawoon W, Seino S, Pason BM, Momin NWS, Kanamori S, Bender C, Takemura K.   +6 more
europepmc   +1 more source

Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study. [PDF]

Vaccines (Basel)
Mejía LR, Mendez LP, Rüttimann RW, Gast C, Bandyopadhyay AS.   +4 more
europepmc   +1 more source

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. [PDF]

NPJ Vaccines, 2021
Wahid R, Mercer L, Macadam A, Carlyle S, Stephens L, Martin J, Chumakov K, Laassri M, Petrovskaya S, Smits SL, Stittelaar KJ, Gast C, Weldon WC, Konopka-Anstadt JL, Steven Oberste M, Van Damme P, De Coster I, Rüttimann R, Bandyopadhyay A, Konz J.   +19 more
europepmc   +1 more source